Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 3
2004 1
2005 5
2006 3
2007 5
2008 3
2009 3
2010 3
2011 5
2012 6
2013 7
2014 7
2015 8
2016 9
2017 4
2018 4
2019 4
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

71 results
Results by year
Filters applied: . Clear all
Page 1
Cardioprotective Potential of Iron Chelators and Prochelators.
Jansová H, Šimůnek T. Jansová H, et al. Among authors: Simunek T. Curr Med Chem. 2019;26(2):288-301. doi: 10.2174/0929867324666170920155439. Curr Med Chem. 2019. PMID: 28933303 Review.
Protective Effects of D-Penicillamine on Catecholamine-Induced Myocardial Injury.
Říha M, Hašková P, Martin J, Filipský T, Váňová K, Vávrová J, Holečková M, Homola P, Vítek L, Palicka V, Šimůnek T, Mladěnka P. Říha M, et al. Among authors: Simunek T. Oxid Med Cell Longev. 2016;2016:5213532. doi: 10.1155/2016/5213532. Epub 2015 Dec 14. Oxid Med Cell Longev. 2016. PMID: 26788248 Free PMC article.
Intravenous rutin in rat exacerbates isoprenaline-induced cardiotoxicity likely due to intracellular oxidative stress.
Filipský T, Říha M, Hašková P, Pilařová V, Nováková L, Semecký V, Vávrová J, Holečková M, Palicka V, Šimůnek T, Hrdina R, Mladěnka P. Filipský T, et al. Among authors: Simunek T. Redox Rep. 2017 Mar;22(2):78-90. doi: 10.1080/13510002.2016.1159817. Epub 2016 Mar 21. Redox Rep. 2017. PMID: 27077454 Free PMC article.
Aroylhydrazone iron chelators: Tuning antioxidant and antiproliferative properties by hydrazide modifications.
Hrušková K, Potůčková E, Hergeselová T, Liptáková L, Hašková P, Mingas P, Kovaříková P, Šimůnek T, Vávrová K. Hrušková K, et al. Among authors: Simunek T. Eur J Med Chem. 2016 Sep 14;120:97-110. doi: 10.1016/j.ejmech.2016.05.015. Epub 2016 May 7. Eur J Med Chem. 2016. PMID: 27187862
Are cardioprotective effects of NO-releasing drug molsidomine translatable to chronic anthracycline cardiotoxicity settings?
Lenčová-Popelová O, Jansová H, Jirkovský E, Bureš J, Jirkovská-Vávrová A, Mazurová Y, Reimerová P, Vostatková L, Adamcová M, Hroch M, Pokorná Z, Kovaříková P, Šimůnek T, Štěrba M. Lenčová-Popelová O, et al. Among authors: Simunek T. Toxicology. 2016 Nov 30;372:52-63. doi: 10.1016/j.tox.2016.11.002. Epub 2016 Nov 2. Toxicology. 2016. PMID: 27816693
Structure-Activity Relationships of Nitro-Substituted Aroylhydrazone Iron Chelators with Antioxidant and Antiproliferative Activities.
Hrušková K, Potůčková E, Opálka L, Hergeselová T, Hašková P, Kovaříková P, Šimůnek T, Vávrová K. Hrušková K, et al. Among authors: Simunek T. Chem Res Toxicol. 2018 Jun 18;31(6):435-446. doi: 10.1021/acs.chemrestox.7b00324. Epub 2018 May 23. Chem Res Toxicol. 2018. PMID: 29766723
Cardioprotective effects of inorganic nitrate/nitrite in chronic anthracycline cardiotoxicity: Comparison with dexrazoxane.
Lenčová-Popelová O, Jirkovský E, Jansová H, Jirkovská-Vávrová A, Vostatková-Tichotová L, Mazurová Y, Adamcová M, Chládek J, Hroch M, Pokorná Z, Geršl V, Šimůnek T, Štěrba M. Lenčová-Popelová O, et al. Among authors: Simunek T. J Mol Cell Cardiol. 2016 Feb;91:92-103. doi: 10.1016/j.yjmcc.2015.12.021. Epub 2015 Dec 23. J Mol Cell Cardiol. 2016. PMID: 26724189
71 results
Jump to page
Feedback